319 related articles for article (PubMed ID: 22061642)
1. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis.
Shanmugavelan P; Nagarajan S; Sathishkumar M; Ponnuswamy A; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7273-6. PubMed ID: 22061642
[TBL] [Abstract][Full Text] [Related]
2. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
[TBL] [Abstract][Full Text] [Related]
3. Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations.
Tripathi RP; Yadav AK; Ajay A; Bisht SS; Chaturvedi V; Sinha SK
Eur J Med Chem; 2010 Jan; 45(1):142-8. PubMed ID: 19846238
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation and characterizations of newly synthesized 1,2,4-triazoles.
Patel NB; Khan IH; Rajani SD
Eur J Med Chem; 2010 Sep; 45(9):4293-9. PubMed ID: 20630629
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Chollet A; Rodriguez F; Inard C; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2012 Jun; 52():275-83. PubMed ID: 22483635
[TBL] [Abstract][Full Text] [Related]
10. Clubbed triazoles: a novel approach to antitubercular drugs.
Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
[TBL] [Abstract][Full Text] [Related]
11. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
[TBL] [Abstract][Full Text] [Related]
12. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
[TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
[TBL] [Abstract][Full Text] [Related]
14. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
[TBL] [Abstract][Full Text] [Related]
15. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
[TBL] [Abstract][Full Text] [Related]
16. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
[TBL] [Abstract][Full Text] [Related]
17. Azide-alkyne cycloaddition en route towards 1H-1,2,3-triazole-tethered β-lactam-ferrocene and β-lactam-ferrocenylchalcone conjugates: synthesis and in vitro anti-tubercular evaluation.
Kumar K; Carrère-Kremer S; Kremer L; Guérardel Y; Biot C; Kumar V
Dalton Trans; 2013 Feb; 42(5):1492-500. PubMed ID: 23108229
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
Kim S; Cho SN; Oh T; Kim P
Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC
Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219
[TBL] [Abstract][Full Text] [Related]
20. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]